{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:53:24Z","timestamp":1648763604155},"reference-count":11,"publisher":"Japanese Circulation Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2020,5,25]]},"DOI":"10.1253\/circj.cj-20-0256","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T22:05:20Z","timestamp":1588975520000},"page":"885-887","source":"Crossref","is-referenced-by-count":0,"title":["Measuring Thrombogenicity in ST-Elevation Myocardial Infarction\u3000\u2015 Mechanistic Insights and Future Directions \u2015"],"prefix":"10.1253","volume":"84","author":[{"given":"Sergio","family":"Buccheri","sequence":"first","affiliation":[{"name":"Department of Medical Sciences and Uppsala Clinical Research Center, Uppsala University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. <i>Eur Heart J<\/i> 2018; 39: 119\u2013177.","DOI":"10.1093\/eurheartj\/ehx393"},{"key":"2","unstructured":"2. Buccheri S, Capodanno D. Long-term antithrombotic pharmacotherapy following ST-elevation myocardial infarction. <i>Minerva Cardioangiol<\/i> 2016; 64: 305\u2013321."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Buccheri S, Capodanno D, James S, Angiolillo DJ. Bleeding after antiplatelet therapy for the treatment of acute coronary syndromes: A review of the evidence and evolving paradigms. <i>Expert Opin Drug Saf<\/i> 2019; 18: 1171\u20131189.","DOI":"10.1080\/14740338.2019.1680637"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Sibbing D, Aradi D, Alexopoulos D, ten Berg J, Bhatt DL, Bonello L, et al. Updated expert consensus statement on platelet function and genetic testing for guiding P2Y12 receptor inhibitor treatment in percutaneous coronary intervention. <i>JACC Cardiovasc Interv<\/i> 2019; 12: 1521\u20131537.","DOI":"10.1016\/j.jcin.2019.03.034"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Capodanno D, Bhatt DL, Eikelboom JW, Fox KAA, Geisler T, Michael Gibson C, et al. Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease. <i>Nat Rev Cardiol<\/i> 2020; 17: 242\u2013257.","DOI":"10.1038\/s41569-019-0314-y"},{"key":"6","unstructured":"6. Buccheri S, James S. Individualized duration of dual antiplatelet therapy guided by risk scores: Ready for prime time? <i>Circ J<\/i> 2020; 84: 153\u2013155."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kikuchi S, Tsukahara K, Ichikawa S, Abe T, Minamimoto Y, Kimura Y, et al. Platelet-derived thrombogenicity measured by total thrombus-formation analysis system in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. <i>Circ J<\/i> 2020; 84: 975\u2013984.","DOI":"10.1253\/circj.CJ-19-1043"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kaikita K, Hosokawa K, Dahlen JR, Tsujita K. Total thrombus-formation analysis system (T-TAS): Clinical application of quantitative analysis of thrombus formation in cardiovascular disease. <i>Thromb Haemost<\/i> 2019; 19: 1554\u20131562.","DOI":"10.1055\/s-0039-1693411"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Capranzano P, Capodanno D, Bucciarelli-Ducci C, Gargiulo G, Tamburino C, Francaviglia B, et al. Impact of residual platelet reactivity on reperfusion in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. <i>Eur Heart J Acute Cardiovasc Care<\/i> 2016; 5: 475\u2013486.","DOI":"10.1177\/2048872615624849"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. <i>Eur Heart J<\/i> 2018; 39: 213\u2013260.","DOI":"10.1093\/eurheartj\/ehx419"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Claassens DMF, Vos GJA, Bergmeijer TO, Hermanides RS, van\u2019t Hof AWJ, van der Harst P, et al. A genotype-guided strategy for oral P2Y12 inhibitors in primary PCI. <i>N Engl J Med<\/i> 2019; 381: 1621\u20131631.","DOI":"10.1056\/NEJMoa1907096"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/84\/6\/84_CJ-20-0256\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T03:20:29Z","timestamp":1590808829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/84\/6\/84_CJ-20-0256\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,25]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-20-0256","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,25]]}}}